Header image

Poster walk, Friday - Informed Choice in Screening: Understanding and Communicating Benefits and Harms

Tracks
Friday, June 20, 2025
11:15 - 12:30
Smedien, Centralvaerkstedet

Speaker(s)

Dr Miriam Clarissa Ortíz Alvarado
Specialist In Prevention Of Cervical Cancer
Jhpiego

215 - Survey of Women’s Awareness, Perspectives on Risk and Benefits of Screening for Cervical Cancer in Burkina Faso, Cote d’Ivoire, Guatemala and the Philippines

Biography

Dr. Mark Kabue is highly skilled and results-oriented Global Health expert with over 20 years of experience in program management, research and learning in several settings especially in Asia, Africa and central America. Recognized for exceptional abilities in implementation research, working with various including USAID, CDC, Unitaid, Bill and Melinda Gates Foundation. He has expertise implementing multi-county programs and research studies and capacity development. Strong applied understanding of HIV/AIDS, Tuberculosis Response, Surveillance, Cervical cancer and Health System Strengthening. Extensive experience working in foreign environments and with persons from different cultures and backgrounds.
Keris Poelhekken
PhD Researcher
University Medical Center Groningen

160 - Understanding the potential side effects of breast cancer screening: overdiagnosis of ductal carcinoma in situ

Biography

Keris Poelhekken was born in Leiden, the Netherlands, and studied Biomedical Engineering at the Rijksuniversiteit Groningen. Currently, she is a third year PhD researcher at the Epidemiology department in the University Medical Center Groningen (UMCG) on the topic of breast cancer screening and overdiagnosis. In this PhD, the influence of several factors on overdiagnosis estimates are quantified with (partially self-constructed) simulation models. The research focuses on ductal carcinoma in situ. Besides the PhD, she is a first year medical physicist resident in radiology and nuclear medicine at the UMCG.
Dr Jazzine Samuel
Research Fellow
University College London

120 - Investigating the effectiveness of a chatbot in promoting National Health Service Bowel Cancer Screening Intentions: a randomised survey

Biography

Currently, as a Research Fellow at University College London, my primary research focuses on developing an innovative chatbot for the NHS Bowel Cancer Screening Programme. With a PhD in Psychology, I am motivated to transform healthcare technology through digital health research. I've contributed to diverse digital health products aimed at improving healthcare accessibility and quality, such as enhancing hearing health and supporting cancer survivors within the NHS. My expertise lies in user engagement and behavioural change theories and I am committed to enhancing user experiences and outcomes.
Agenda Item Image
Dr Danielle Timmermans
Full Professor
Dept Public Health, Amsterdam UMC, Vrije Universiteit

331 - Risk information in breast cancer screening:Women’s awareness, beliefs, and preferences

Biography

Danielle Timmermans is professor of Public Health Risk Communication and head of the research group RISC Amsterdam, which is in the Netherlands the leading research group on perception and communication of health risks. Research focuses on how to inform and communicate with the public about health and safety risk in order to foster informed and deliberate decision making about e.g. prenatal screening, cancer screening, vaccination, and environmental risks. Research is done in collaboration with societal and professional parties, such as the National Institute of Public Health. She advises for several health programs and to several ministries in the Netherlands.

Chair(s)

Lindy Kregting
Post-doc Epidemiologist
Radboudumc

Return to the ICSN Website here

 

 

#ICSN25

loading